News

Drug Delivery Business1h
Glucotrack can proceed with long-term glucose monitor study in Australia
Glucotrack (Nasdaq:GCTK) announced today that it received a hospital's ethical approval to study its continuous blood glucose ...
Drug Delivery Business5h
Dexcom promotes Jake Leach to president role
Dexcom (Nasdaq:DXCM) announced today that it promoted Jake Leach to the role of president, in addition to his post as COO.
Drug Delivery Business30m
Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
Tandem Diabetes Care shared that its Capillary Biomedical (CapBio) subsidiary won FDA 510(k) clearance for a new infusion set.